Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season

One of the main challenges in early clinical research with respiratory syncytial virus (RSV) live-attenuated vaccines (LAVs) is to assess immunogenicity in healthy adults. Healthy adults will have preexisting levels of serum neutralizing antibodies that could prematurely neutralize the LAV and under...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hum Vaccin Immunother
Hlavní autoři: Van Der Plas, Johan L., Verdijk, Pauline, Van Brummelen, Emilie M. J., Jeeninga, Rienk E., Roestenberg, Meta, Burggraaf, Jacobus, Kamerling, Ingrid M.C.
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2019
Témata:
Short Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7482755/
https://ncbi.nlm.nih.gov/pubmed/31674870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1688040
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky